<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Singh et al. Infectious Diseases poverty 2013, 2:5 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br />  RESEARCH ARTICLE                                                                                                                                 Open Access <br />  <br /> In vitro gene silencing independent <br /> phosphoglycerate mutase (iPGM) filarial <br /> parasite Brugia malayi <br /> Prashant Kumar Singh, Susheela Kushwaha, Shahab Mohd, Manisha Pathak Shailja Misra-Bhattacharya* <br />  <br />  <br />   <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />   Background: The phosphoglycerate mutase (PGM) enzyme catalyzes interconversion 2- 3- <br />   phosphoglycerate glycolytic /gluconeogenic pathways present majority cellular organisms. <br />   They classified cofactor-dependent PGM (dPGM) cofactor-independent PGM (iPGM). Vertebrates, yeasts, <br />   bacteria dPGM, higher plants, nematodes, archaea, bacteria only <br />   iPGM. A small number bacteria, including Escherichia coli certain archaea protozoa, contain forms. <br />   The silencing ipgm Caenorhabditis elegans (C. elegans) demonstrated importance enzyme in <br />   parasite viability and, therefore, potential anthelmintic drug target. In study, role Brugia <br />   malayi (B. malayi) ipgm parasite viability, microfilaria release, embryogenesis, vivo development infective <br />   larvae post-gene silencing explored applying ribonucleic acid (RNA) interference studies. <br />   Results: The vitro ipgm gene silencing small interfering RNA (siRNA) leads severe phenotypic deformities in <br />   intrauterine developmental stages female worms drastic reduction (~90%) motility adult <br />   parasites significantly reduced (80%) release microfilariae (mf) female worms vitro. Almost half the <br />   vitro-treated infective L3 displayed sluggish movement. The vivo <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span>survival</span> development siRNA-treated <br />   infective larvae (L3) investigated peritoneal cavity jirds ~45% reduction adult worm <br />   establishment observed. <br />   Conclusion: The findings clearly suggest iPGM essential larval adult stages B. malayi parasite <br />   plays pivotal role female worm embryogenesis. The results validate Bm-iPGM putative <br />   anti-filarial drug target. <br />   Keywords: siRNA, Lymphatic filariasis, Drug target, RNAi, Embryogenesis <br />  <br />  <br /> Multilingual abstract                                                                   1.39 billion people remain risk infection [1]. <br /> Please Additional file 1 translations abstract                           The subclinical condition associated patent infection <br /> into official working languages United                                   include acute manifestations, adenolym- <br /> Nations.                                                                                phangitis, acute dermatolymphangioadenitis, tropical <br />                                                                                         pulmonary eosinophilia rarely life threatening. <br />                                                                                         However, chronic manifestations, lymphedema <br /> Background                                                                              (elephantiasis) hydrocele debilitating, accounting <br /> Lymphatic filariasis (LF) vector-borne helminth                                    nearly million disability-adjusted life years [2,3]. <br /> disease caused slender nematodes, Wuchereria                                         Current control measures LF include annual doses of <br /> bancrofti, Brugia malayi (B. malayi), B. timori. This                               diethylcarbamazine ivermectin alone, combi- <br /> incapacitating disease infects 120 million people                               nation albendazole, principally targets micro- <br /> 72 tropical subtropical countries,                                  filariae (mf) little action adult worms [4,5]. <br />                                                                                         Target-based anthelmintic drug discovery nas- <br /> * Correspondence: shailja_cdri@rediffmail.com <br /> Division Parasitology, CSIR-Central Drug Research Institute, B.S. 10/1, Sector <br />                                                                                         cent stage drug targets identified <br /> 10, Jankipuram Extension, Sitapur Road, Lucknow 226021, UP, India                       filarial parasites utilizing approach. The publication <br />                                           &#194;&#169; 2013 Singh et al.; licensee BioMed Central Ltd. This Open Access article distributed terms Creative <br />                                           Commons Attribution License (http://creativecommons.org/licenses/by/2.0), permits unrestricted use, distribution, and <br />                                           reproduction medium, provided original work properly cited. <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                            Page 2 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> of draft assembly B. malayi genome followed        pellet diet water ad libitum. The animals the <br /> an expansion transcriptomic genomic datasets          animal experimental procedures approved the <br /> facilitated identification vital enzymes proteins   Animal Ethics Committee Institute, duly consti- <br /> filarial parasites exploited drug targets. This   tuted provisions Committee the <br /> would assist designing potential anti-         Purpose Control Supervision Experiments on <br /> filarial compounds understanding gene functions        Animals (CPCSEA), Government India. The study <br /> [6,7].                                                           bears approval no. 129/08/Para/IAEC/renew (84/09), <br />    The gene silencing ribonucleic acid (RNA) interfer-        dated 27.04.2009. <br /> ence (RNAi) landmark discovery area <br /> of biomedical research. RNAi provided functional           Parasites culture <br /> genomics platform unravel functions various            The B. malayi infective larvae (L3) recovered <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> genes associations disease state       laboratory bred vector mosquito, Aedes aegypti <br /> organism. &#226;&#8364;&#732;Target validation&#226;&#8364;&#8482; inherent aspect       fed 9 &#194;&#177; 1 days earlier donor Mastomys <br /> drug discovery process, accom-               (multimammate mouse-Mastomys coucha) [13]. The L3 <br /> plished silencing mRNA expression given              isolated gently-crushed mosquitoes using <br /> gene situ, using specific inhibitors        Baermann technique, washed repeatedly the <br /> target enzyme/protein observe deleterious effect        Ringer&#226;&#8364;&#8482;s solution, counted. The six- eight- week <br /> on organism. With exceptions, RNAi            old male jirds infected inoculating 100&#226;&#8364;&#8220;150 L3 <br /> been utilized extent parasitic nematodes,         peritoneal cavity animal. The adult <br /> including filariids [8]. RNAi Caenorhabditis elegans       parasites mf recovered washing the <br /> (C. elegans), surrogate model B. malayi,          peritoneal cavity jirds 120 180 days of <br /> explored identify novel genes involved nematode        intra-peritoneal infection. The mf collected after <br /> biology comparative genomics studies proposed           passing peritoneal lavage 5.0 &#206;&#188;m mem- <br /> a number molecular targets anti-parasitic drugs [9].      brane filter (Whatman, USA). The parasites washed <br /> Another gene identified RNAi C. elegans 2,          repeatedly fresh culture medium RPMI 1640 <br /> 3-bisphosphoglycerate independent phosphoglycerate               (Sigma, USA) containing 100 units/ml penicillin and <br /> mutase (iPGM). This enzyme&apos;s sequence structure           100 &#206;&#188;g/ml streptomycin sulfate (Invitrogen, USA), <br /> completely different 2, 3-bisphosphoglycerate           transferred adequate volume fresh <br /> -dependent phosphoglycerate mutase (dPGM)               medium, preheated 37&#194;&#176;C ready be <br /> mammals [10]. Both enzymes responsible               used RNAi experimentation. Undamaged, healthy, <br /> interconversion 2-phosphoglycerate 3-phospho-             similar-sized, highly motile worms sexes, with <br /> glycerate different catalytic mechanisms. The           females releasing near similar count live mf, <br /> regulation iPGM C. elegans RNAi resulted             selected RNAi experimentation. <br /> embryonic larval lethality [11]. Outcomes RNAi <br /> experiments carried C. elegans              Design synthesis siRNA <br /> match parasitic helminths and, therefore,            The custom-designed synthesized gene-specific <br /> becomes mandatory carry gene silencing tar-        siRNAs Bm-iPGM used study procured <br /> get parasite itself [12]. The current investigation reports      Ambion, USA. The highest-ranking sense anti- <br /> on RNAi mediated ipgm gene silencing adult            sense siRNA duplexes representing best combination <br /> infective larval stages human lymphatic filarial parasite,    activity specificity provided con- <br /> B. malayi. Using small size (small interfering) RNA              centration 40 nmoles lyophilized powder. Stock <br /> (siRNA), effect observed parasite viability,      solutions 100 &#206;&#188;M prepared stored &#226;&#710;&#8217;20&#194;&#176;C <br /> the mf release, adverse effect embryogenesis       use. The 50-30 sequences sense antisense <br /> the female worm, vivo development          strands siRNA were: <br /> treated infective larvae (L3) adult parasites the <br /> peritoneal cavity jirds.                                        Sense (CCA UUG UGC UGA AAC AGA Att) <br />                                                                    Antisense (UUC UGU UUC AGC ACA AUG Gaa) <br /> Methods <br /> Animals                                                            The siRNA (#AM 4621, Ambion) completely unrelated <br /> Purpose-bred, parasite na&#195;&#175;ve, six- eight-week old, male       B. malayi, does target gene product, was <br /> jirds (Meriones unguiculatus) used study.            used negative control determine off-target effects, <br /> Animals maintained proper housing conditions             any. The negative control siRNA did any <br /> at animal house facility Central Drug Research         sequence similarity mouse, rat, human gene <br /> Institute (CDRI) Lucknow, India, fed standard           sequences, pretested (Ambion) cell- <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                             Page 3 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> based screens proven significant effect      incubation. Of female worms obtained from <br /> on cell proliferation, viability, morphology.            tubes, frozen TRIzol reagent <br />                                                             later use PCR, remaining six <br /> Demonstration vitro siRNA uptake parasites using   females male worms transferred fresh <br /> fluorescence microscopy                                     siRNA-free medium incubated another <br /> The penetration siRNA B. malayi adult females,      48 hours replacing medium fresh normal <br /> L3, mf observed soaking parasites      medium 24 hours. At end experiment, <br /> Cy3-labelled negative siRNA. Four female worms, 50 L3,      i.e. 48 hours shifting siRNA-free medium, <br /> and 100 mf soaked medium containing             females teased uterine <br /> 2 &#206;&#188;M siRNA separately 24 hours 37&#194;&#176;C. All    contents observed microscopically determine <br /> parasite stages washed repeatedly PBS (pH 7.4),     effect gene silencing embryogenesis evalua- <br /> the fluorescence visualized, parasites     ting relative proportion various intrauterine <br /> photographed fluorescence microscope (Nikon,        progenies. The females frozen TRIzol <br /> Japan) using rhodamine filter set emission wave-    reagent PCR analysis, remaining two <br /> <span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> 590 nm.                                           females male worms checked motility, <br />                                                             viability, vitro mf release culture medium <br /> siRNA treatment B. malayi adult worms soaking     discussed above. The experiment repeated twice <br /> method                                                      number worms identical condi- <br /> The RNAi carried adult worms       tions data expressed mean &#194;&#177; SD the <br /> sexes soaking method. We used groups        experiments. <br /> our experiments. The control group did receive any <br /> siRNA treatment worms kept normal           The effect gene silencing vitro release mf <br /> siRNA-free culture medium. The negative control group       phenotypic changes <br /> received siRNA completely unrelated         The mf pellets, various time points, suspended <br /> B. malayi experimental group received         50 &#206;&#188;l PBS mentioned above, 10 &#206;&#188;l this <br /> Bm-iPGM specific siRNA. The adult parasites (four           suspension used triplicate assessing number <br /> female male worms) taken midi           mf released vitro. For observing phenotypic <br /> GebaFlex tubes (cut 5 kDa) containing 1 mM spermi-      changes, smear mf suspension a <br /> dine, 8U RNaseOUT (Invitrogen, USA), 5 &#206;&#188;M siRNA          glass slide, later fixed stained Giemsa <br /> in 800 &#206;&#188;l RPMI medium fortified 10% fetal           photographed (Nikon, Japan). <br /> bovine serum (Invitrogen, USA) medium, such <br /> tubes kept beaker containing 300 ml            The motility score viability B. malayi adult <br /> medium preheated 37&#194;&#176;C. The beaker tubes         worms <br /> was placed CO2 incubator 37&#194;&#176;C tubes         The viability male female worms was <br /> were retracted various time periods. The tube      assessed mitochondrial reduction 3-[4,5- <br /> was removed 12 hours incubation adult      dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide <br /> worms tube transferred fresh siRNA-      (MTT, Sigma) formazan, described earlier [14]. <br /> free medium. The leftover medium tube            The formation formazan quantified spec- <br /> centrifuged 800&#195;&#8212;g minutes, pellet    trophotometrically 530 nm multiplate reader <br /> resuspended 50 &#206;&#188;l medium obser-      (Tecan, Infinite M200, Switzerland), percent <br /> vation compound microscope assess          inhibition MTT reduction treated parasite <br /> number <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span>phenotype</span> vitro released mf. Of        control worms assessed. The motility <br /> the female worms, frozen TRIzol            scoring adult worms carried shown <br /> reagent later preparation nucleic acid measure    percentage reduction motility of <br /> mRNA expression Bm-ipgm. The remaining               worm control evaluated. The <br /> females males transferred fresh pre-    worms displaying movement transfer <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span> <br /> heated culture medium (37&#194;&#176;C) 30 minutes,      fresh siRNA-free medium considered and <br /> motility assessed individually scored. The viabi-   scored dead (see Table 1). <br /> lity worm subsequently checked MTT <br /> reduction assay using dye 3-(4,5 dimethylthiazol-       Table 1 Criterion motility scoring adult worms <br /> 2-yl)-2,5 diphenyltetrazolium bromide. The remaining                             Motility adult worms <br /> three tubes removed one 24 hours,         % Inhibition   0   1 25   26 49   50 74   75 99   100 <br /> 36 hours 48 hours, processed same <br />                                                                Score       5     4          3          2          1       Dead <br /> way. The leftover tubes removed 60 hours <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                            Page 4 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> Table 2 The PCR primers used quantitative                       fresh siRNA-free medium. The L3 totally <br /> RT-PCR analyses                                                         immotile did display sign reversal the <br /> Target Gene       Primer       Primers (50-30)                     motility medium replenishment considered to <br /> Bm-ipgm           Bm-ipgm F         50 GCT GAT AAG GTG ATT GAG 30       dead. The L3 individual wells separately <br />                   Bm-ipgm R         50 CAG TTA CCA TCA GTA TGT AG 30    frozen TRIzol reagent analysis Bm-iPGM tran- <br /> Bm-tub-1          Bm-tub F          5 ACT TGG TGT CCG AAT ATC30         script levels. Another set experiments conducted <br />                   Bm-tub R          50ACTCTTCCTGTTCAATGTAT30 <br />                                                                         observe vivo development vitro siRNA <br />                                                                         treated larvae naive jirds. The L3 soaked in <br />                                                                         gene-specific siRNA, non-target siRNA, control <br /> Measurement mRNA expression Bm-ipgm                           media manner 24 hours, <br /> The loss specific transcripts following RNAi treat-              followed washing siRNA-free medium, 100 <br /> ment examined real-time quantitative RT-PCR                      actively motile L3 subsequently inoculated in <br /> (qRT-PCR). The B. malayi &#206;&#178;-tubulin gene (Bm-tub-1)                      peritoneal cavity 6-week old male jird. A total of <br /> was used endogenous control gene. For qRT-PCR,                    jirds/ experiment inoculated 100 L3 <br /> the primers designed Beacon designer                      active live larvae used for <br /> software (see Table 2). The frozen worms homoge-                   infecting jirds. The jirds euthanized 120 days <br /> nized TRIzol reagent RNA extracted                   post-infection parasites isolated by <br /> as described earlier [15]. The strand cDNA                    repeated washing peritoneal cavity. The parasites <br /> generated using Super Script III strand cDNA                  counted, measured, females later teased <br /> synthesis kit (Invitrogen, USA) using oligo (dT) 20                     individually drop PBS observe intrauterine <br /> primers. The specific cDNA fragments amplified                     development. <br /> by real-time PCR (Roche, USA) using SYBR <br /> premix. The PCR conditions qRT-PCR 95&#194;&#176;C                    Statistical analysis <br /> 5 minutes, followed 40 cycles 95&#194;&#176;C 20 seconds,                The data analyzed using one-way two-way (for <br /> 56&#194;&#176;C 15 seconds, 72&#194;&#176;C 30 seconds. The rela-                 grouped data) analysis variance (ANOVA) the <br /> tive target amplicon experiment                   help statistical software PRISM 5.0. The individual <br /> determined comparative &#206;&#8221;CT method. The value                     comparisons following ANOVA using the <br /> of control group (siRNA-free medium) set                     Bonferroni method Newman-Keuls Multiple <br /> 100%, relative reduction RNAi treated groups                 Comparison Test, applicable. The criterion of <br /> was calculated expressed percentage reductions.                  evaluating statistical significance experi- <br />                                                                         mental control groups follows: p value &lt;0.05 <br /> The silencing Bm-ipgm gene infective L3                       considered significant marked *, p &lt;0.01 as <br /> Two L3 kept wells                  highly significant marked **, p &lt;0.001 was <br /> a 48-well plate containing 1 ml culture medium fortified                highly significant marked ***. <br /> with 1 mM spermidine 8 U RNAse OUT. Of the <br /> three wells, contained 2 &#206;&#188;M gene specific siRNAs,                   Results <br /> another contained non-target siRNA,                 The soaking method successfully delivered siRNA <br /> one devoid siRNA. The plate incubated                     All parasite stages incubated vitro the <br /> 37&#194;&#176;C 5% CO2 24 48 hours, motility                  presence 2 &#206;&#188;M concentration Cy3-labeled negative <br /> the L3 scored 30 minutes transfer                   control siRNA ensure proper uptake siRNA by <br />  <br />  <br />  <br />  <br />  Figure 1 Confirmation penetration siRNA mf, L3, adult female worms. The Cy3-labeled negative control siRNA taken up <br />  stages parasite vitro soaking 24 hours 2 &#206;&#188;M concentration. The fluorescence visualized using Nikon <br />  fluorescence microscope using rhodamine filter set emission 590 nm. <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                                    Page 5 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br />                                                                                   worms sluggish appearance compared <br />                                                                                   female worms experimental groups. The <br />                                                                                   siRNA-treated parasites showed reduced viability in <br />                                                                                   MTT reduction tests, however, male female <br />                                                                                   worms remained alive end experiment <br />                                                                                   (60 hours), 48 hours transfer the <br />                                                                                   siRNA-free medium (total 108 hours). The treated <br />                                                                                   worms demonstrated continuous decrease their <br />                                                                                   motility increasing duration incubation in <br />                                                                                   specific siRNA, motility data correlated with <br />                                                                                   inhibition MTT reduction. Maximum inhibitions in <br />                                                                                   MTT reductions treated female male worms were <br />                                                                                   observed 75.9% 89.4%, respectively. After <br />   Figure 2 The vitro siRNA treatment adult female B. malayi                 36 hours soaking medium-containing target <br />   leads reduction microfilaria release. Tubes containing              siRNA, sexes adult parasites demonstrated &#226;&#8240;&#165;50% <br />   adult worms treated 5 &#206;&#188;M siRNA different time                inhibition MTT reduction exhibits significant <br />   periods (12, 24, 36, 48, 60 hours). After 60 hours treatment, six <br />                                                                                   adverse effect parasite viability [16]. <br />   females cultured days fresh siRNA-free <br />   normal culture medium (108 hours). The percent reduction the <br />   mf release analyzed Bm-iPGM-specific siRNA-treated and <br />   negative control group control media group. There              The Bm-ipgm silencing impairs release mf the <br />   significant reduction release mf Bm-iPGM siRNA-              female worms, mf motility phenotype vitro <br />   treated worms starting 12 hours continuing until <br />                                                                                   The mf released controls siRNA-treated <br />   108 hours. The criterion statistical significance the <br />   results carried ANNOVA expressed form                 female B. malayi culture medium counted. A <br />   p value considered significant marked p &lt;0.05 *,             considerable drop noticed number mf <br />   p &lt;0.01 highly significant **, p &lt;0.001 *** highly               released Bm-ipgm specific siRNA-treated female <br />   significant. Data represent mean &#194;&#177; SE percent reduction mf                parasites 24 hours incubation, decreased <br />   counts independent experiments. <br />                                                                                   ~80% (p &lt;0.001) 48 hours, indicating a <br />                                                                                   potent adverse effect gene silencing mf release. <br /> the soaking method. The siRNA uptake occurred success-                            This effect remained unchanged transferring <br /> fully stages B. malayi 24 hours soaking                     worms siRNA-free medium. No <span id='am-239' about='xsp:pattern' typeof='owl:Thing'>pattern</span> <br /> (see Figure 1). Fluorescence clearly detected                         observed non-specific siRNA-treated control <br /> 24 hours hypodermis, intestine, uterus                          worms (see Figure 2). In addition, complete loss of <br /> female worms, L3 mf, siRNA                              motility witnessed ~80% released mf <br /> visualized body filarial parasites.                         (these appeared dead) 24 hours exposure and <br />                                                                                   partial paralysis observed remaining 20% mf <br /> The silencing B. malayi ipgm gene impairs                              (these seldom slight movement anterior <br /> adult B. malayi viability                                                         posterior portion tips). The phenotypic deformities in <br /> The siRNA-mediated silencing Bm-ipgm gene                               mf conspicuous contraction body at <br /> the soaking method resulted reduced motility                            end, leaving mf sheath empty. Besides <br /> both male female worms compared                             this, small large vacuoles visible in- <br /> control worms, exposed                                   non-motile mf Bm-ipgm specific siRNA- <br /> normal, medium, negative siRNA (see Table 3). Male                             treated group (see Figure 3). <br />  <br /> Table 3 Effect Bm-ipgm gene silencing adult male female B. malayi <br />                           Motility score                    % Inhibition MTT                  Motility score               % Inhibition MTT <br />                          (female worms)                         reduction                        *(male worms)                    reduction <br /> Time (hr)    Control     Negative      Gene specific     Negative      Gene specific   Control   Negative   Gene specific   Negative     Gene specific <br />                           siRNA           siRNA           siRNA           siRNA                   siRNA        siRNA         siRNA          siRNA <br />    12            5            5               4          2.25 &#194;&#177; 3.3      29.9 &#194;&#177; 5.4      5          5             4         2.5 &#194;&#177; 1.3      26.8 &#194;&#177; 4.5 <br />    24            5            5               3           4.5 &#194;&#177; 1.2      40.2 &#194;&#177; 6.2      5          5             3         4.5 &#194;&#177; 1.3      38.8 &#194;&#177; 6.5 <br />    36            4            5               3           5.0 &#194;&#177; 2.3      55.4 &#194;&#177; 6.3      4          4             2         4.5 &#194;&#177; 2.6      64.4 &#194;&#177; 5.4 <br />    48            4            4               2           6.2 &#194;&#177; 2.8      74.4 &#194;&#177; 3.4      4          4             1          6 &#194;&#177; 1.8       80.2 &#194;&#177; 6.8 <br />   108            4            4               2          6.26 &#194;&#177; 2.3      75.9 &#194;&#177; 4.7      4          4             1         5.25 &#194;&#177; 2.6     89.4 &#194;&#177; 5.3 <br /> Key: *0%: 5; 1 25%: 4; 26 49%: 3; 50 74%: 2; 75-99%: 1; 100%: Dead. <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                                Page 6 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> The Bm-ipgm gene silencing profound adverse                           (~40%) noted, complete morphogenesis <br /> effects female worm embryogenesis                                      failed. The remaining stages consisted of <br /> At end experiment (108 hours initiation                  eggs, early embryos, pretzel and, full-grown mf. The si- <br /> of RNAi treatment), female worms collected                       lencing Bm-ipgm gene caused abnormality in <br /> for preparing embryogram (see Figure 4). The rela-                    phenotypes eggs mf. All develop- <br /> tive proportion various progenies different stages               ing stages appeared normal culture medium de- <br /> development displayed good proportions                        void target siRNA, non-target probe (see <br /> intrauterine contents form degenerated eggs                     Figure 3). <br />  <br />  <br />  <br />  <br />  Figure 3 The Bm-ipgm specific gene silencing causes developmental defects mf eggs. The Giemsa-stained mf from <br />  control group (A), siRNA-free negative control group (B), Bm-iPGM specific siRNA-treated group (C) exhibited stretched mf sheaths. <br />  The mf control groups (D E) normal phenotypes compared Bm-iPGM-specific siRNA treatment led variable <br />  phenotypes mf including degenerating internal contents containing vacuoles (F, arrows). The mf control groups were <br />  alive (G, H), specific siRNA-treated group dead (I). The eggs control groups (J, K) normal, those <br />  iPGM specific siRNA (L) degenerated, showing increased spaces eggshell embryo. <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                               Page 7 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br />  Figure 4 The effect siRNA B. malayi female worm <br />  embryogenesis. The embryograms female worms exposed <br />  culture medium, negative siRNA, Bm-iPGM             Figure 5 The percent reduction gene transcript level Bm- <br />  -specific siRNA (5 &#206;&#188;M) examined 108 hours incubation.    ipgm specific siRNA treated worms. Two female worms different <br />  The data expressed percentages eggs, early developing        time intervals (12, 24, 36, 48, 60 hours) 48 hours transfer to <br />  stages, pretzel, mf.                                               normal siRNA-free culture medium removed analyzed for <br />                                                                         differences Bm-ipgm gene-specific transcript levels qRT-PCR. The <br /> Soaking adult B. malayi Bm-ipgm siRNA-                    relative amounts iPGM amplicon determined using the <br />                                                                         comparative &#206;&#8221;CT method normalizing endogenous <br /> containing medium leads loss Bm-iPGM <br />                                                                         control gene (Bm-tub-1). The median value control group was <br /> transcript                                                              set 100% reduction expression treated groups was <br /> The qRT-PCR results showed Bm-ipgm gene                        calculated percentage control. The criterion statistical <br /> silencing resulted transcript reduction relative              significance results carried ANNOVA was <br /> the expression &#206;&#178;-tubulin control gene                     expressed form p value considered significant and <br />                                                                         marked p &lt;0.05 *, p &lt;0.01 highly significant **, p &lt;0.001 *** <br /> 12 hours, continued 60 hours. This <br />                                                                         highly significant. Data represent mean &#194;&#177; SE percent <br /> reduction gene expression profile siRNA-                  reduction mf counts independent experiments. <br /> soaked worms irreversible 48 hours of <br /> transfer siRNA-free medium (see Figure 5). The <br /> control worms revealed presence Bm-iPGM                     death 48 hours observation. There ~65% <br /> transcript time points study. The reduction              reduction Bm-iPGM transcript level revealed <br /> in Bm-iPGM specific transcript level highly                    qRT-PCR L3 24 48 hours obser- <br /> significant (p &lt;0.001) compared negative                 vation (see Figure 6A). The surviving active motile <br /> control, negligible (5-8%) reduction. The data               L3 groups different batches were <br /> have represented percentage reduction                   separately inoculated peritoneal cavity the <br /> the gene expression normalized using &#206;&#178;-tubulin (Bm-                    na&#195;&#175;ve jirds observe vivo development of <br /> tub-1) transcript housekeeping gene control. The                L3s. There 44.36% reduced recovery rate <br /> reduction transcript levels correlated            (p &lt;0.01) adult parasites jirds euthanized <br /> reduction release mf target specific                day 120, comparison recovered from <br /> siRNA-treated female worms, phenotypic abnormalities,                  control jirds (see Figure 6B). A proportion recovered <br /> and complete loss motility released                 female worms (24.9 &#194;&#177; 6.8%) experimental jirds con- <br /> mf, adverse effects intrauterine                tained degenerated intrauterine contents (see Figure 6C). <br /> development.                                                           An interesting observation relative establish- <br />                                                                        ment female worms low jirds infected <br /> The Bm-ipgm gene silencing infective L3 reduces                 target gene specific siRNA-treated L3 contrast <br /> their motility impairs development jirds          female worm recovery control groups. <br /> In vitro silencing Bm-ipgm gene L3 brought               The sizes adult parasites marginally <br /> about reduction motility half cul-              shorter isolated control jirds (see <br /> tured L3 48 hours contrast control group,                 Table 5). <br /> where 10-12% L3 sluggish. Under normal <br /> culture conditions normal medium, 25%                    Discussion <br /> of L3 non-motile considered dead.                  Phosphoglycerate mutases enzymes catalyze <br /> A similar effect observed target siRNA-                interconversion 2- 3-phosphoglycerate the <br /> treated group (see Table 4) demonstrating noticeable                glycolytic/gluconeogenic pathways present in <br /> adverse effects siRNA larval viability. However,             cellular organisms. High-throughput RNAi studies <br /> gene silencing profound adverse effects L3                  performed C. elegans identified genes <br /> motility leading sluggishness amounting                  essential parasite viability including cofactor- <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                                      Page 8 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> Table 4 The effect Bm-iPGM siRNA treatment morphology infective larvae (L3) <br /> Infective Larvae                           Control                                  Negative control                      Bm-iPGM specific siRNA <br /> condition <br />                                  24 h                   48 h                   24 h                   48 h              24 h                    48 h <br /> Active (%)                    82.5 &#194;&#177; 4.9             58.5 &#194;&#177; 12.0             82.5 &#194;&#177; 7.7             57.5 &#194;&#177; 9.1        49 &#194;&#177; 2.12               23.5 &#194;&#177; 9.1 <br /> Sluggish (%)                  10.0 &#194;&#177; 2.8              17.5 &#194;&#177; 3.5             12.5 &#194;&#177; 3.5             17.0 &#194;&#177; 5.6        37.0 &#194;&#177; 2.12             50.5 &#194;&#177; 3.5 <br /> Dead* (%)                      7.5 &#194;&#177; 2.2              24.0 &#194;&#177; 8.4             10.0 &#194;&#177; 2.8             25.5 &#194;&#177; 3.5        14.0 &#194;&#177; 4.24            26.0 &#194;&#177; 12.7 <br /> *: These non-motile L3 reversal motility noticed transfer siRNA-free medium. <br />  <br /> independent phosphoglycerate mutase (iPGM) [17-20].                               malayi [40]. Recently, vivo silencing dem- <br /> The iPGM present nematodes, bacteria,                            onstrated Aedes aegypti, mosquito vector B. <br /> and trypanosomes exception bacteria,                             malayi [41]. We recently reported use of <br /> such E. coli, certain archaea protozoa                            19 bp siRNA successfully silence B. malayi RNA heli- <br /> contain iPGM dPGM forms. [21-27].                                    case soaking electroporation methods [42]. <br /> Because absence vertebrates key                             Selection siRNAs appropriate given sequence <br /> role pathogen development, enzyme shows great                             prime importance mainly based struc- <br /> potential possible drug/vaccine candidate. In                           tural attributes, optimal length, concentration, <br /> study, attempts investigate functional                           requirement 3&#226;&#8364;&#8482; dinucleotide overhang, low <br /> role B. malayi ipgm gene parasite viability, mf                         G/C content [43-46]. Initially, used 21 bp siRNA for <br /> release, embryogenesis, vivo infective L3 develop-                         soaking mf, L3, adult worms 2 &#206;&#188;M concentra- <br /> ment RNAi mediated silencing using important                               tion Cy3-labeled, non-specific siRNA, showed a <br /> life stages B. malayi, L3 adult worms.                                 successful penetration siRNA parasite <br />    The RNAi discovered accidentally C. elegans                             stages. However, 5 &#206;&#188;M siRNA used soaking <br /> [28,29] tried parasitic nematodes                          adult parasites experiments, concentration <br /> variable limited success. Nippostrongylus brasiliensis                        effective bring silencing effects <br /> was nematode RNAi effects                                previous studies. For gene silencing L3, <br /> reported using double-stranded RNAs (dsRNAs) [30]                             lower concentration (2 &#206;&#188;M) siRNA used L3s <br /> since then, RNAi reported various                             demonstrated better absorption siRNA lower <br /> nematodes, Haemonchus contortus [31-33], As-                              concentration. The low concentrations small-sized <br /> caris suum [34-36], Trichostrongylus colubriformis [35,37],                       dsRNA/siRNA produce more <br /> O. volvulus [38,39], Ostertagia ostertagi [37], B.                            effective gene silencing effects opposed high <br />  <br />  <br />  <br />  <br />   Figure 6 Effect siRNA Bm-ipgm gene transcription L3 stage production adult worms. (A) siRNA treatment of <br />   infective larvae (L3) resulted significant loss Bm-iPGM transcript level 24 48 hours incubation. (B) The number recovered <br />   male female worms control, negative control, Bm-ipgm-specific treated L3 implanted jirds. The Bm-ipgm-specific siRNA-treated <br />   L3 exhibited 44.36% reduction adult worm establishment peritoneal cavity naive male jird, significant (p &lt;0.01) over <br />   control. (C) The percentage sterile female worms recovered control, negative control, Bm-ipgm-specific treated L3 implanted jirds. A <br />   significant number female worms recovered siRNA-treated group displayed defective embryogenesis. The recovered females were <br />   teased drop PBS glass slide condition intrauterine contents analyzed microscopically (Nikon). The percentage sterile <br />   female worms calculated respect total female worms recovered analyzed. The criterion statistical significance between <br />   results carried ANNOVA expressed form p value considered significant marked p &lt;0.05 *, <br />   p &lt;0.01 highly significant **, p &lt;0.001 *** highly significant. The data represent mean &#194;&#177; SE percent reduction mf counts <br />   independent experiments. <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                  Page 9 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> Table 5 Measurement worm length recovered                       female parasites. The profound decrease the <br /> jirds infected siRNA-treated untreated infective               number mf released specific siRNA-treated <br /> larvae                                                                  female worms indicated deleterious effects worm <br /> Groups                                    Worm length (cm &#194;&#177; S.D.)       function. The released mf revealed phenotypic defor- <br />                                      Female               Male          mities form contracted body end, leav- <br /> Control                              3.47 &#194;&#177; 0.57          1.67 &#194;&#177; 0.34   ing long sheath end, internal <br /> Negative control                     3.48 &#194;&#177; 0.65          1.75 &#194;&#177; 0.25   vacuole formation subsequent loss motility, <br /> Bm-iPGM specific siRNA               2.60 &#194;&#177; 0.70          1.58 &#194;&#177; 0.29   amounting death. The relative proportion various <br />                                                                         progenies demonstrated failure complete morphogen- <br />                                                                         esis. The number free mf pretzel stages within <br /> concentrations induce stress parasites. The                 uteri female worms showed considerable <br /> small-sized siRNA reduces innate immune interferon                  reduction increased proportion early egg stages <br /> response produces negligible non-target effects                     showing impairment transformation divided <br /> [42,47-49]. The single siRNA computationally                        eggs pretzel stages. This been <br /> designed custom synthesized Ambion target                     brought insufficient production energy <br /> Bm-iPGM.                                                                needed germ-cell differentiation iPGM a <br />    Several studies reported off-target effects               crucial enzyme parasite glycolytic pathway. It has <br /> gene silencing and, therefore, use                     shown mitochondrial content regulated <br /> siRNA recommended confer effective gene                     transition different parasitic stages and <br /> silencing. To confirm observed effects                    different stages different energy requirements [51]. <br /> gene specific, negative control completely unrelated               iPGM involved fundamental metabolic pathway and <br /> B. malayi used study. However, use                   shown C. elegans expressed through- <br /> another siRNA specific Bm-iPGM given                      worm developmental stages, being <br /> our results credibility. In previous studies,              abundant cells higher metabolic rates, such <br /> have used single siRNA target specific genes                    contracting body wall muscles, nerve ring, the <br /> interest substantially successful gene silen-               intestinal cells. <br /> cing observing off-target effects [38,46]. The                The disruption C. elegans iPGM RNAi <br /> soaking method used, described earlier [40,42,50],               brought variable defects, including embryonic and <br /> with substantial modifications. Worms kept dif-                 larval lethality [11]. Almost half vitro siRNA- <br /> ferent tubes tube taken                treated L3 sluggish, 25% remained <br /> time point touching remaining worms                  totally immotile transfer normal culture <br /> other tubes. This avoid mechanical                      media considered &#226;&#8364;&#732;dead&#226;&#8364;&#8482;. Even though, the <br /> damage, stress, contamination remaining para-                 gene silencing effects conspicuous motility <br /> sites requiring longer incubation. The loss gene tran-               viability L3, lead death. The <br /> script level started 12 hours soaking                  possible reason infective L3 survival the <br /> Bm-iPGM specific siRNA, apparent                      abundant storage iPGM enzyme worm body, <br /> end experiment, showing reversal                    slow sustained depletion iPGM tran- <br /> after 48 hours transfer worms                      script 90%, 100%. A single concentration <br /> siRNA-free medium. The loss gene function slowed                     siRNA used current study high <br /> down motility male female parasites.                cost, however, increasing duration siRNA treat- <br /> The percent inhibition parasite motility correlated                  ment use different concentrations siRNA may <br /> very MTT assay, quantitative                   possibly shown dose dependent effects B. malayi. <br /> assay widely used evaluation vitro                 A successful RNAi experiment depends various <br /> anti-filarial activity compounds B. malayi                   factors, including culture conditions, route/mode of <br /> worms. There specific knockdown Bm-                        siRNA delivery, gene targeted, site, level of <br /> iPGM transcript range deleterious effects               expression parasite, parasite itself. This <br /> on phenotypes, however, additional studies                indicates differences nematodes uptake <br /> be performed detect degree protein knock-                     spread dsRNA/siRNA been <br /> down. This limited number experi-                     reason variation results obtained with <br /> mental control worms, utilized                   different parasites. Silencing iPGM C. elegans <br /> assessing parameters thought import-                   differing outcomes of <br /> ant study.                                                      differences RNAi methodology used and <br />    The measurement mf release culture                Zhang et al., 2004 [10]. The used dsRNA <br /> robust method ensure ill effects gene silencing               instead siRNA, used study. The <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                           Page 10 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> dsRNA/siRNA design inform variable efficiencies         present various parasites, including filariids. The <br /> of different dsRNAs/siRNAs individual transcript           siRNA treatment led phenotypic deformities <br /> sensitivities individual species,   intrauterine stages treated female worms. A <br /> have reasons differences              drastic reduction (~90%) noticed adult parasite <br /> observed. However, C. elegans, embryonic lethality     motility significant reduction (80%) the <br /> started 18 24 hours, reaching maximum          vitro release mf female worms. Almost half <br /> 94% 50 60 hours post injection dsRNA.            vitro-treated L3 displayed sluggish movement. <br />   The vivo survival development siRNA-          The important aspect study observation <br /> treated L3 investigated peritoneal inocu-      vivo survival development siRNA- <br /> lation naive jirds euthanizing animals      treated L3 jirds showed ~45% reduction the <br /> on day 120 observe establishment larvae       adult worm establishment. The information obtained <br /> into adult parasites. The vivo results demonstrated    study clearly indicates necessity Bm- <br /> the inability good proportion treated infective   iPGM life cycle B. malayi, emphasizes its <br /> L3s reach adult stage. Not this,              major role female worm embryogenesis. The study vali- <br /> established adult worms profound retardation           dates Bm-iPGM potent anti-filarial drug target that <br /> their lengths recovered control       utilized design novel inhibitors. Further struc- <br /> groups. In addition, unusually low recovery      tural docking studies underway facilitate the <br /> rate female worms, half         design synthesis Bm-iPGM inhibitors that <br /> recovered males. This differential Bm-          facilitate anti-filarial drug discovery programs. <br /> ipgm expression patterns male female worms. In <br /> one study, shown approximately 4%         Additional file <br /> genes associated glycolysis gluconeogenesis <br /> in male worms compared 1% female worms           Additional file 1: Multilingual abstracts official working <br /> [52]. Thus, silencing ipgm        languages United Nations. <br />  <br /> fatal effect carbohydrate metabolism female <br /> worms resulting reduced recovery. The control        Competing interests <br />                                                               The authors declare competing interests. <br /> groups twice number female worms <br /> than male worms, quite usual B. malayi-           Authors&#226;&#8364;&#8482; contributions <br /> infected animals. The recovered female worms         SMB conceived study, analyzed data, drafted manuscript. <br /> experimental group displayed defective embryogen-        PKS SK initiated study, performed molecular RNAi <br />                                                               experiments, analyzed data, drafted manuscript. MS MP <br /> esis. These vivo studies confirm role iPGM       contributed experimentation. All authors contributed the <br /> nematode metabolism, growth, fecundity. The ad-           writing manuscript approved submitted version. <br /> verse effects iPGM gene silencing growth have <br />                                                               Acknowledgements <br /> been demonstrated earlier variety plants hu-      The authors acknowledge Council Scientific Industrial Research <br /> man parasites. The double iPGM mutants Arabidopsis         (CSIR), University Grants Commission (UGC), Indian Council for <br /> thaliana iPGM antisense potato plants showed              Medical Research, New Delhi, India, financial assistance form of <br />                                                               Senior Research Fellowships PKS, SK, MS, MP. The financial assistance <br /> severely-retarded plant growth correlated           form CSIR Network Project SplenDID gratefully <br /> the decreased concentrations phosphoenolpyruvate           acknowledged. We thank Mr. A. K. Roy Mr. R. N. Lal excellent <br /> [53,54]. The iPGM required normal growth        technical assistance maintenance B. malayi infection the <br />                                                               laboratory. This article bears CSIR-CDRI communication number 8421. <br /> Trypanosoma brucei procyclic [26] blood stream <br /> form [55], proposed drug target          Received: 2 December 2012 Accepted: 21 March 2013 <br /> spore-forming Bacillus species tomato pathogen,           Published: 25 March 2013 <br /> Pseudomonas syringae [56,57]. <br />                                                               References <br />   The present findings clearly demonstrate vital role     1. WHO: Weekly epidemiological record. World Health Organisation 2011, <br /> of iPGM, metabolic enzyme parasite growth,               35:377&#226;&#8364;&#8220;388. <br /> validates Bm-iPGM possible anti-filarial drug target.    2. WHO: Lymphatic filariasis: reasons hope. Geneva: World Health <br />                                                                   Organization; 1997:1&#226;&#8364;&#8220;20. <br />                                                               3. WHO: Lymphatic filariasis elimination. Report meeting principles for <br /> Conclusion                                                        enhancement public/private partnership. Amsterdam, The <br /> The identification validation anti-filarial drug           Netherlands; 1999:1&#226;&#8364;&#8220;14. <br />                                                               4. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KS, Abeyewickrema <br /> target/s extreme importance currently           W, Rezvi-Sheriff MH, Rajaratnam HN, Amarasekera N, Silva DC, Michalski <br /> no adulticidal anti-filarial drug. RNAi widely           ML, Dissanaike AS: Efficacy single dose combinations albendazole, <br /> used validate identify drug targets,              ivermectin diethylcarbamazine treatment bancroftian <br />                                                                   filariasis. Trans R Soc Trop Med Hyg 1998, 92:94&#226;&#8364;&#8220;97. <br /> PGM enzyme forms: verte-             5. Sharma DC: New goals set filariasis elimination India. Lancet Infect <br /> brates contain dPGM form, iPGM                   Dis 2002, 2:389. <br />  Singh et al. Infectious Diseases poverty 2013, 2:5                                                                                                     Page 11 12 <br /> http://www.idpjournal.com/content/2/1/5 <br />  <br />  <br />  <br />  <br /> 6.    Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, Crabtree J, Allen JE, Delcher AL,          metal ions active site different susceptibilities irreversible <br />       Guiliano DB, Miranda-Saavedra D, Angiuoli SV, Creasy T, Amedeo P, Haas B,              chemical modification. Eur J Biochem 2004, 271:1798&#226;&#8364;&#8220;1810. <br />       El-Sayed NM, Wortman JR, Feldblyum T, Tallon L, Schatz M, Shumway M,             25.   Besteiro S, Barrett MP, Riviere L, Bringaud F: Energy generation insect <br />       Koo H, Salzberg SL, Schobel S, Pertea M, Pop M, White O, Barton GJ, Carlow             stages Trypanosoma brucei: metabolism flux. Trends Parasitol 2005, <br />       CK, Crawford MJ, Daub J, Dimmic MW, Estes CF, Foster JM, Ganatra M,                    21:185&#226;&#8364;&#8220;191. <br />       Gregory WF, Johnson NM, Jin J, Komuniecki R, Korf I, Kumar S, Laney S, Li        26.   Djikeng A, Raverdy S, Foster J, Bartholomeu D, Zhang Y, El-Sayed NM, Carlow <br />       BW, Li W, Lindblom TH, Lustigman S, Ma D, Maina CV, Martin DM, McCarter                C: Cofactor-independent phosphoglycerate mutase essential gene in <br />       JP, McReynolds L, Mitreva M, Nutman TB, Parkinson J, Peregrin-Alvarez JM,              procyclic form Trypanosoma brucei. Parasitol Res 2007, 100:887&#226;&#8364;&#8220;892. <br />       Poole C, Ren Q, Saunders L, Sluder AE, Smith K, Stanke M, Unnasch TR, Ware       27.   Foster JM, Davis PJ, Raverdy S, Sibley MH, Raleigh EA, Kumar S, Carlow CKS: <br />       J, Wei AD, Weil G, Williams DJ, Zhang Y, Williams SA, Fraser-Liggett C, Slatko         Evolution Bacterial Phosphoglycerate Mutases: Non-Homologous <br />       B, Blaxter ML, Scott AL: Draft genome filarial nematode parasite                Isofunctional Enzymes Undergoing Gene Losses, Gains Lateral <br />       Brugia malayi. Science 2007, 317:1756&#226;&#8364;&#8220;1760.                                            Transfers. PLoS One 2010, 5(10):e13576. <br /> 7.    Scott AL, Ghedin E, Nutman TB, McReynolds LA, Poole CB, Slatko BE, Foster        28.   Guo S, Kemphues KJ: par-1, gene required establishing polarity C. <br />       JM: Filarial Wolbachia genomics. Parasite Immunol 2012, 34:121&#226;&#8364;&#8220;129.                elegans embryos, encodes putative Ser/Thr kinase is <br /> 8.    Viney ME, Thompson FJ: Two hypotheses explain RNA                               asymmetrically distributed. Cell 1995, 81:611&#226;&#8364;&#8220;620. <br />       interference does work animal parasitic nematodes. Int J Parasitol        29.   Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and <br />       2008, 38:43&#226;&#8364;&#8220;47.                                                                        specific genetic interference double-stranded RNA Caenorhabditis <br /> 9.    Kumar S, Chaudhary K, Foster JM, Novelli JF, Zhang Y, Wang S, Spiro D,                 elegans. Nature 1998, 391:806&#226;&#8364;&#8220;811. <br />       Ghedin E, Carlow CKS: Mining predicted essential genes Brugia malayi          30.   Hussein AS, Kichenin K, Selkirk ME: Suppression secreted <br />       nematode drug targets. PLoS One 2007, 2(11):e1189.                                 acetylcholinesterase expression Nippostrongylus brasiliensis RNA <br /> 10.   Jedrzejas MJ: Structure, function, evolution phosphoglycerate                   interference. Mol Biochem Parasitol 2002, 122:91&#226;&#8364;&#8220;94. <br />       mutases: comparison fructose-2,6-bisphosphatase, acid                       31.   Geldhof P, Murray L, Couthier A, Gilleard JS, McLauchlan G, Knox DP, Britton <br />       phosphatase, alkaline phosphatase. Prog Biophys Mol Biol 2000,                     C: Testing efficacy <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-238' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span> Haemonchus contortus. <br />       73:263&#226;&#8364;&#8220;287.                                                                            Int J Parasitol 2006, 36:801&#226;&#8364;&#8220;810. <br /> 11.   Zhang Y, Foster JM, Kumar S, Fougere M, Carlow CK: Cofactor-independent          32.   Kotze AC, Bagnall NH: RNA interference Haemonchus contortus: <br />       phosphoglycerate mutase essential role Caenorhabditis                        suppression beta-tubulin gene expression L3, L4 adult worms <br />       elegans conserved parasitic nematodes. J Biol Chem 2004,                     vitro. Mol Biochem Parasitol 2006, 145:101&#226;&#8364;&#8220;110. <br />       279:37185&#226;&#8364;&#8220;37190.                                                                 33.   Samarasinghe B, Knox DP, Britton C: Factors affecting susceptibility RNA <br /> 12.   Landmann F, Foster JM, Slatko BE, Sullivan W: Efficient vitro RNA                   interference Haemonchus contortus vivo silencing H11 <br />       interference immunofluorescence-based phenotype analysis                      aminopeptidase gene. Int J Parasitol 2011, 41:51&#226;&#8364;&#8220;59. <br />       human parasitic nematode, Brugia malayi. Parasit Vectors 2012, 5:16.             34.   Islam MK, Miyoshi T, Yamada M, Tsuji N: Pyrophosphatase the <br /> 13.   Singh U, Misra S, Murthy PK, Katiyar JC, Agrawal A, Sircar AR:                         roundworm Ascaris suum plays essential role worm&apos;s molting <br />       Immunoreactive molecules Brugia malayi diagnostic                         development. Infect Immun 2005, 73:1995&#226;&#8364;&#8220;2004. <br />       potential. Serodiag Immun Inf D 1997, 8:207&#226;&#8364;&#8220;212.                                 35.   Issa Z, Grant WN, Stasiuk S, Shoemaker CB: Development methods for <br /> 14.   Mukherjee M, Misra S, Chatterjee RK: Optimization test conditions               RNA interference sheep gastrointestinal parasite, Trichostrongylus <br />       development MTT vitro screen. Indian J Exp Biol 1997, 35:73&#226;&#8364;&#8220;76.               colubriformis. Int J Parasitol 2005, 35:935&#226;&#8364;&#8220;940. <br /> 15.   Kushwaha S, Singh PK, Rana AK, Misra-Bhattacharya S: Cloning, expression,        36.   Chen N, Xu MJ, Nisbet AJ, Huang CQ, Lin RQ, Yuan ZG, Song HQ, Zhu XQ: <br />       purification kinetics trehalose-6-phosphate phosphatase filarial             Ascaris suum: RNAi mediated silencing enolase gene expression in <br />       parasite Brugia malayi. Acta Trop 2011, 119:151&#226;&#8364;&#8220;159.                                   infective larvae. Exp Parasitol 2011, 127:142&#226;&#8364;&#8220;146. <br /> 16.   Misra-Bhattacharya S, Katiyar D, Bajpai P, Tripathi RP, Saxena JK: 4-Methyl-7-   37.   Visser A, Geldhof P, Maere V, Knox DP, Vercruysse J, Claerebout E: <br />       (tetradecanoyl)-2H-1-benzopyran-2-one novel DNA topoisomerase II                     Efficacy specificity RNA interference larval life-stages of <br />       inhibitor macrofilaricidal embryostatic activity sub-                 Ostertagia ostertagi. Parasitology 2006, 133:777&#226;&#8364;&#8220;783. <br />       periodic Brugia malayi. Parasitol Res 2004, 92:177&#226;&#8364;&#8220;182.                          38.   Lustigman S, Zhang J, Liu J, Oksov Y, Hashmi S: RNA interference targeting <br /> 17.   Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M,                      cathepsin L Z-like cysteine proteases Onchocerca volvulus <br />       Ahringer J: Functional genomic analysis C. elegans chromosome I                  confirmed essential function L3 molting. Mol Biochem <br />       systematic RNA interference. Nature 2000, 408:325&#226;&#8364;&#8220;330.                                 Parasitol 2004, 2004(138):165&#226;&#8364;&#8220;170. <br /> 18.   Gonczy P, Echeverri C, Oegema K, Coulson A, Jones SJ, Copley RR, Duperon         39.   Ford L, Guiliano DB, Oksov Y, Debnath AK, Liu J, Williams SA, Blaxter ML, <br />       J, Oegema J, Brehm M, Cassin E, Hannak E, Kirkham M, Pichler S, Flohrs K,              Lustigman S: Characterization novel filarial serine protease inhibitor, <br />       Goessen A, Leidel S, Alleaume AM, Martin C, Ozlu N, Bork P, Hyman AA:                  Ov-SPI-1, Onchocerca volvulus, potential multifunctional roles <br />       Functional genomic analysis cell division C. elegans using RNAi               development parasite. J Biol Chem 2005, 280:40845&#226;&#8364;&#8220;40856. <br />       genes chromosome III. Nature 2000, 408:331&#226;&#8364;&#8220;336.                               40.   Aboobaker AA, Blaxter ML: Use RNA interference investigate gene <br /> 19.   Piano F, Schetter AJ, Mangone M, Stein L, Kemphues KJ: RNAi analysis                function human filarial nematode parasite Brugia malayi. Mol <br />       genes expressed ovary Caenorhabditis elegans. Curr Biol 2000,                Biochem Parasitol 2003, 129:41&#226;&#8364;&#8220;51. <br />       10:1619&#226;&#8364;&#8220;1622.                                                                    41.   Song C, Gallup JM, Day TA, Bartholomay LC, Kimber MJ: Development of <br /> 20.   Maeda I, Kohara Y, Yamamoto M, Sugimoto A: Large-scale analysis gene                vivo R <br /> </body></html>